Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 507-509, 2003; 10.1373/49.3.507
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diefenbach, K.
Right arrow Articles by Roots, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diefenbach, K.
Right arrow Articles by Roots, I.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2003;49:507-509.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Rapid Genotyping of Melanocortin-1 Receptor with Use of Fluorescence-labeled Oligonucleotides

Konstanze Diefenbach1a, Przemyslaw M. Mrozikiewicz1, Britta Brien1, Olfert Landt2 and Ivar Roots1

1 Institute of Clinical Pharmacology, Charité, Humboldt University of Berlin, 10117 Berlin, Germany

2 TIB Molbiol, Syntheselabor, 10829 Berlin, Germany

aaddress correspondence to this author at: Institute for Clinical Pharmacology, University Hospital Charité, Schumannstrasse 20/21, 10117 Berlin, Germany; fax 49-30-450-525932, e-mail konstanze.diefenbach{at}charite.de

The melanocortin-1 receptor (MC1R), localized on chromosome 16q24.3, is a G-protein-coupled receptor expressed mostly in melanocytes. Melanotropic ligands such as {alpha}-melanocyte-stimulating hormone and adrenocorticotropic hormone act via MC1R and regulate the proportion of the photo-protective melanins eumelanin and pheomelanin, which may contribute to ultraviolet (UV) radiation-induced skin damage (1) by favoring the synthesis of eumelanin. Individuals with red hair have a predominance of pheomelanin in hair and skin and/or a reduced ability to produce eumelanin, which may explain why they fail to tan and suffer from increased cutaneous UV sensitivity and why UV irradiation is more dangerous for them. Fair skin and red hair are also associated with an increased risk of cutaneous malignant melanoma (2)(3). Recently, some polymorphic variants of MC1R have been associated with red hair and found to be overrepresented in individuals with fair skin (4)(5)(6)(7), particularly the Arg151Cys, Arg160Trp, and Asp294His variants (1)(4). These variants correlate with an increased risk of malignant melanoma (7)(8)(9). The association between MC1R variants and malignant cutaneous melanoma suggests that the MC1R gene is a susceptibility gene for this skin malignancy (10).

Heritable factors should be taken into consideration when measuring cutaneous UV sensitivity of substances with a phototoxic potential. Because MC1R may be a genetic determinant of individual skin sensitivity toward UV irradiation, we developed LightCycler assays for the detection of common MC1R polymorphisms. This rapid-cycle PCR combined with real-time fluorescence monitoring and melting point analysis is able to detect polymorphisms in ~1 h.

LightCycler methods were established for all common (>1%) and/or functional polymorphisms (11)(12)(13) (see Table 1 ). Genomic DNA from 100 volunteers was extracted from peripheral blood by standard methods. Primers and LightCycler hybridization probes (see Table 1 ) were developed according to the MC1R sequence (OMIM 15555; GenBank accession no. NM_002386). For some primers and hybridization probes, mismatches were incorporated either to destabilize folded motifs in the target or to optimize the differentiation in the melting analysis (see Val60Leu, Arg160Trp, and Arg163Gln in Table 1 ). The probes were labeled using the respective LightCycler Red640 ester or Red705 amidite according to the manufacturer’s instruction (Roche Diagnostics). Two of the assays were established for simultaneous detection of two mutations each (see Val92Met and Thr95Met, and Arg160Trp and Arg163Gln in Table 1 ). Because of low allele frequencies (<1%), two polymorphisms (Thr95Met and Asp294His) were not detected in our 100 volunteers. Melting data of these variants are given according to assays using synthetic oligonucleotides covering the wild type or the mutated variant (see Table 1 ).


View this table:
[in this window]
[in a new window]
 
Table 1. Conditions for detection of mutations in MC1R, including oligonucleotide primer, hybridization probes, melting peaks, and PCR conditions.

All PCRs were performed in a total volume of 20 µL in LightCycler glass capillaries. The reaction mixture contained 0.2 µM each primer, 0.1 µM each of the anchor and sensor, 0.1 mM deoxynucleotide triphosphates, 30 mg/L bovine serum albumin, 50 mL/L dimethyl sulfoxide, 2 µL of 10x Taq Buffer, 1 µL of the sample (containing 20–30 ng/µL genomic DNA), 1 U of Taq polymerase, and assay-specific amounts of MgCl2 (2.5–6.3 mM; see Table 1Up ) and was adjusted to the final volume of 20 µL with distilled water. The PCR conditions in the LightCycler (Roche Diagnostics) were as follows: initial denaturation at 95 °C for 40 s, followed by 45 cycles of denaturation at 95 °C for 5 s, 10 s of annealing at assay-specific temperatures (see Table 1Up ), and extension at 72 °C for 10 s.

After amplification the melting analysis was performed by denaturation at 98 °C for 0 s and annealing at 40 °C for 20 s; the temperature was increased continuously up to 85 °C with a ramp rate of 0.1 °C/s. Fluorescence was recorded during the heating period, and the melting curves (F/T) were converted to melting peaks (-dF/dT). The melting peak analysis showed well-differentiated temperatures for all polymorphisms (see Table 1Up ). The melting curves for the typing of two variants (Arg160Trp and Arg163Gln) are shown in Fig. 1 as examples.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Melting profiles of representative samples of the three detected MC1R genotypes at position 160 (Arg->Trp) and 163 (Arg->Gln).

LightCycler results were compared with the results achieved by PCR–restriction fragment length polymorphism typing (11)(14)(15) and DNA sequencing (PrismTM 310 Genetic Analyzer; Applied Biosystems Applera) and correlated perfectly.

In conclusion, the established LightCycler-based assays offer a fast, accurate, and reproducible method for detecting point mutations in MC1R by melting curve analysis. Thus, they can be valuable tools for the screening of volunteers or patients when evaluating cutaneous UV sensitivity.


References

  1. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995;11:328-330.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  2. Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer 1995;62:367-376.[ISI][Medline] [Order article via Infotrieve]
  3. Kricker A, Armstrong BK, English DR, Heenan PJ. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer: a case-control study. Int J Cancer 1991;48:650-662.[ISI][Medline] [Order article via Infotrieve]
  4. Box NF, Wyeth JR, O’Gorman LE, Martin NG, Sturm RA. Characterisation of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 1997;6:1891-1897.[Abstract/Free Full Text]
  5. Smith R, Healy E, Siddiqui S, Flanagan N, Steijlen PM, Rosdahl I, et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 1998;111:119-122.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  6. Flanagan N, Healy E, Ray A, Philips S, Todd C, Jackson IJ, et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 2000;9:2531-2537.[Abstract/Free Full Text]
  7. Palmer JS, Duffy DL, Box NF, Aitken JF, O’Gorman LE, Green AC, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?. Am J Hum Genet 2000;66:176-186.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  8. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996;5:1663-1666.[Abstract/Free Full Text]
  9. Healy E, Todd C, Jackson IJ, Birch-Machin M, Rees JL. Skin type, melanoma, and melanocortin 1 receptor variants. J Invest Dermatol 1999;112:512-513.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  10. Rees JL, Healy E. Melanocortin receptors, red hair, and skin cancer. J Investig Dermatol Symp Proc 1997;2:94-98.[Medline] [Order article via Infotrieve]
  11. Koppula SV, Robbins LS, Lu DS, Baack E, White CR, Swanson NA, et al. Identification of common polymorphisms in the coding sequence of the human MSH receptor (MC1R) with possible biological effects. Hum Mutat 1997;9:30-36.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  12. Frändberg PA, Doufexis M, Kapas S, Chhajlani V. Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor. Biochem Biophys Res Commun 1998;245:490-492.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  13. Schiöth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JES, Rees JL. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 1999;260:488-491.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  14. Chhajlani V, Wikberg JE. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992;309:417-420.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  15. Ichii-Jones F, Lear JT, Heagerty AH, Smith AG, Hutchinson PE, Osborne J, et al. Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol 1998;111:218-222.[CrossRef][ISI][Medline] [Order article via Infotrieve]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diefenbach, K.
Right arrow Articles by Roots, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diefenbach, K.
Right arrow Articles by Roots, I.
Related Collections
Right arrow Molecular Diagnostics and Genetics


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS